Latham, NY, United States of America

Ren Hua Song

This inventor holds 1 USPTO granted patent. Top assignees: Deltagen Research Labs, LLC, Icos Corporation. Active years: 2005.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Ren Hua Song. Retrieved from https://idiyas.com/inventor/ren-hua-song

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


Average Co-Inventor Count = 18.0

ph-index = 1

Forward Citations = 22(Granted Patents)


Company Filing History:


Years Active: 2005

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Ren Hua Song: Innovator in PARP Inhibitors

Introduction

Ren Hua Song is a notable inventor based in Latham, NY (US). He has made significant contributions to the field of pharmaceuticals, particularly in the development of PARP inhibitors. His innovative work has led to the creation of compounds that have the potential to impact cancer treatment.

Latest Patents

Ren Hua Song holds a patent for PARP inhibitors. The present invention provides compounds comprising a bicyclic aryl moiety, such as 2H-phthalazin-1-one or derivatives thereof. The patent includes compositions comprising these compounds and methods for producing and using them. In particular, the invention provides compounds of a specific formula, or a pharmaceutically acceptable salt, a hydrate, a solvate, or a prodrug thereof.

Career Highlights

Throughout his career, Ren Hua Song has worked with prominent companies in the biotechnology sector. He has been associated with Icos Corporation and Deltagen Research Labs, LLC. His experience in these organizations has contributed to his expertise in drug development and innovation.

Collaborations

Ren Hua Song has collaborated with several professionals in his field. Notable coworkers include Graham Beaton and Wilna J Moree. These collaborations have likely enriched his research and development efforts.

Conclusion

Ren Hua Song is a distinguished inventor whose work on PARP inhibitors showcases his commitment to advancing medical science. His contributions have the potential to make a significant impact in the treatment of diseases, particularly cancer.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…